Related Experiment Videos
Combating opiate dependence: a comparison among the available pharmacological options
Gerardo Gonzalez1, Alison Oliveto, Thomas R Kosten
1Department of Psychiatry,Yale University School of Medicine, West Haven, CT 06516, USA. Gerardo.Gonzalez-Haddad@yale.edu
Expert Opinion on Pharmacotherapy
|April 23, 2004
Summary
Pharmacotherapies for heroin addiction manage withdrawal symptoms and prevent relapse using opioid agonists, antagonists, and alpha-2 agonists. Medications like buprenorphine and naltrexone are key for detoxification and long-term maintenance.
Area of Science:
- Addiction Medicine
- Pharmacology
- Neuroscience
Background:
- Pharmacotherapies are crucial for managing heroin addiction, addressing withdrawal and relapse.
- Available treatments include opioid agonists, partial agonists, antagonists, and alpha-2 agonists.
Purpose of the Study:
- To review the rationale, indications, and limitations of pharmacotherapies for heroin addiction.
- To focus on medications for opioid detoxification and relapse prevention.
Main Methods:
- Review of existing literature on pharmacotherapies for heroin addiction.
- Discussion of various medication classes and their application in treatment.
Main Results:
- Opioid agonists, partial agonists, antagonists, and alpha-2 agonists are available for withdrawal management and maintenance.
- Buprenorphine and naltrexone are highlighted for their roles in office-based maintenance and reducing diversion.
Conclusions:
- Pharmacotherapy plays a vital role in heroin addiction treatment, aiming to relieve withdrawal and prevent relapse.
- Medications support both detoxification and long-term abstinence maintenance.